Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Pasinetti

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Molecular and Chemical Neuropathology|August 1, 1997
Complement and glutamate neurotoxicity. Genotypic influences of C5 in a mouse model of hippocampal neurodegenerationG Tocco, W Musleh, S Sakhi, et al.
Experimental Neurology|May 1, 1999
Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexusJ T Chun, L Wang, G M Pasinetti, et al.
Neurobiology of Aging|November 1, 1992
Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioningS A Johnson, M Lampert-Etchells, G M Pasinetti, et al.
Journal of Cellular Biochemistry|December 1, 1993
TGF-beta 1 is an organizer of responses to neurodegenerationC E Finch, N J Laping, T E Morgan, et al.
Journal of Neurochemistry|November 1, 1990
Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpineG M Pasinetti, D G Morgan, S A Johnson, et al.
Neuroscience|June 1, 1993
Transforming growth factor beta 1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localizationG M Pasinetti, N R Nichols, G Tocco, et al.
Journal of Neuroscience Research|July 21, 1999
Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's diseaseL Ho, C Pieroni, D Winger, et al.
Biochemical and Biophysical Research Communications|November 15, 1994
Purification and characterization of brain clusterinT Oda, G M Pasinetti, H H Osterburg, et al.
Molecular Psychiatry|December 7, 2005
Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's diseaseW Qin, Y Peng, H Ksiezak-Reding, et al.
Neuroscience|September 1, 1994
Response of striatal astrocytes to neuronal deafferentation: an immunocytochemical and ultrastructural studyH W Cheng, T Jiang, S A Brown, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Molecular and Chemical Neuropathology|August 1, 1997
Complement and glutamate neurotoxicity. Genotypic influences of C5 in a mouse model of hippocampal neurodegenerationG Tocco, W Musleh, S Sakhi, et al.
Experimental Neurology|May 1, 1999
Glycoprotein 330/megalin (LRP-2) has low prevalence as mRNA and protein in brain microvessels and choroid plexusJ T Chun, L Wang, G M Pasinetti, et al.
Neurobiology of Aging|November 1, 1992
Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioningS A Johnson, M Lampert-Etchells, G M Pasinetti, et al.
Journal of Cellular Biochemistry|December 1, 1993
TGF-beta 1 is an organizer of responses to neurodegenerationC E Finch, N J Laping, T E Morgan, et al.
Journal of Neurochemistry|November 1, 1990
Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpineG M Pasinetti, D G Morgan, S A Johnson, et al.
Neuroscience|June 1, 1993
Transforming growth factor beta 1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localizationG M Pasinetti, N R Nichols, G Tocco, et al.
Journal of Neuroscience Research|July 21, 1999
Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's diseaseL Ho, C Pieroni, D Winger, et al.
Biochemical and Biophysical Research Communications|November 15, 1994
Purification and characterization of brain clusterinT Oda, G M Pasinetti, H H Osterburg, et al.
Molecular Psychiatry|December 7, 2005
Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's diseaseW Qin, Y Peng, H Ksiezak-Reding, et al.
Neuroscience|September 1, 1994
Response of striatal astrocytes to neuronal deafferentation: an immunocytochemical and ultrastructural studyH W Cheng, T Jiang, S A Brown, et al.
Pageof 7